Remove topics mock-trials
article thumbnail

Pharma and Biotech Patent Litigation Summit returns to Amsterdam with IPKat readers’ discount

The IPKat

This 3-day conference promises to offer 200+ private practice and in-house participants a forum of practical discussions surrounding the leading patent litigation topics in Europe, with a compare-and-contrast method with jurisdictions further afield. A UPC Litigation Forum will take place on 22 January too.

article thumbnail

AIPPI Congress (Report 3): Soft IP update, wine & IP and the metaverse

The IPKat

While many Congress attendees from around the world lined up for the Unified Patent Court boot camp and mock trial panels, this Katfriend opted to sample the day’s selection of soft IP offerings. Jurisdiction in the global metaverse was another topic that presented intriguing questions and as of yet few answers.

IP 76
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

[UPDATE] Calls to push back UPC sunrise period as 89% have not been able to obtain/authenticate security devices needed to access Case Management System

The IPKat

The survey has been running for almost a week and garnered several comments and emails on the topic. Delay to the sunrise period is required: There were reports that a suggested 2-3 week delay might be under consideration (as reported at the UPC Mock Trial in Paris last week). Merpel is still taking a nap.

article thumbnail

Cardozo A&ELJ symposium, Trademark

43(B)log

And this move—firmly distinguishing source confusion from other kinds of confusion, this time with a statutory basis, would have salutary effects on free speech and competitive freedom to operate, which are topics I believe the other speakers will take up in more detail. Trial court hated VIP! As in MGA v. But are parodies really safe?

article thumbnail

Supreme Court on Patent Law for October 2022

Patently-O

Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) My favorite part of this litigation is the mock-up created by folks at the USPTO of Gil Hyatt applying the “Submarine Prosecution Chokehold.”